Obesity Clinical Trials in New York

Showing 41-60 of 256 trials

A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity

NCT06046443

The goal of this study is to determine how well LB54640 works and how safe it is in patients with Hypothalamic Obesity (HO). The study will evaluate the effect of LB54640 on safety, weight reduction, hunger, and quality of life in patients 12 years of age and older with HO. Patients will take an oral daily dose of either LB54640 (low, middle, or high dose) or placebo through Week 14. Eligible patients who consent to continue in the study after Week 14 will take an oral daily dose of LB54640 through Week 56.

Hypothalamic Obesity

Rhythm Pharmaceuticals, Inc.28 participantsStarted Jul 2024

Aurora, Colorado, United States • Iowa City, Iowa, United States • Boston, Massachusetts, United States +7 more locations

Enrolling By InvitationPhase 2< 1 mile

A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)

NCT07156578

This is a long-term, open-label extension study of bivamelagon in participants with Hypothalamic Obesity (HO) who have transitioned from the index study, LG-MCCL005. The study will last up to 2 years.

Hypothalamic Obesity

Rhythm Pharmaceuticals, Inc.25 participantsStarted Nov 2025

Aurora, Colorado, United States • Iowa City, Iowa, United States • Boston, Massachusetts, United States +6 more locations

A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity

A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)

Obesity Trials in Other Cities

Human Models of Selective Insulin Resistance: Pancreatic Clamp

A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight

Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients

Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo

Pancreatic Clamp in NAFLD

Gastric Ultrasound in Patients Who Have Undergone Bariatric Surgery

A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

A Phase 2b, Dose-range Finding Study of the Efficacy and Safety of Multiple Doses of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial

A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity

A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs Alone

A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity

A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity

STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss

A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment

Other Conditions in New York